Quidel Corporation operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Quidel with three other
companies in this sector in the United States:
Meridian Bioscience, Inc.
(2016
sales of $196.08 million
of which 74%
was US Diagnostics),
Neogen Corporation
($321.28 million
of which 55%
was Animal Safety), and
Trinity Biotech PLC
($99.61 million
of which 74%
was Clinical Laboratory).

Sales Analysis.
Quidel reported sales of $191.60 million
for the
year ending
December of 2016.
This
represents
a
decrease of 2.3%
versus 2015, when the company's sales were $196.13 million.